Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis.The Lancet. Respiratory medicine · 2022
   Pooled it
2. From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.Human vaccines & immunotherapeutics · 2025
   Review
3. Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.Acta pharmaceutica Sinica. B · 2025
   Article
4. EMSIG: Uncovering Factors Influencing COVID-19 Vaccination Across Different Subgroups Characterized by Embedding-Based Spatial Information Gain.Vaccines · 2024
   Article
5. Predicting herd immunity achievement: a time-series analysis of vaccination and fatality rates using 1,075 days of COVID-19 data.Frontiers in public health · 2024
   Article
6. Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada.Scientific reports · 2023
   Article
7. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.Infection · 2023
   Article
8. Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review.World journal of meta-analysis · 2023
   Article
9. Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant.Frontiers of medicine · 2023
   Article
10. Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people.Frontiers in immunology · 2023
    Observational
11. Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia.Infectious disease reports · 2022
    Article
12. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.Human vaccines & immunotherapeutics · 2022
    Article
13. Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.Science translational medicine · 2022
    Article
14. Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older persons.American journal of physiology. Endocrinology and metabolism · 2022
    Article
15. Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines.Vaccines · 2022
    Article

Corrections and comments

• Comment on
  Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.2022

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as